Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Comerc Energia subsidiary Hélio Valgas Solar swings to Q3 profit of R$ 72.88 million

Comerc Energia subsidiary Hélio Valgas Solar swings to Q3 profit of R$ 72.88 million

BitgetBitget2026/11/05 19:53
  • Hélio Valgas Solar Participações, a Comerc Energia subsidiary, posted third-quarter 2026 consolidated net profit of BRL 72.88 million.
  • The result reversed a BRL 109.71 million year-earlier loss; net revenue fell to BRL 67.52 million from BRL 86.54 million.
  • Net financial income reached BRL 43.96 million, versus a net financial expense of BRL 111.4 million a year earlier.
  • Nine-month consolidated net loss narrowed to BRL 6.71 million from BRL 598.87 million a year earlier.
  • Cash rose to BRL 161.54 million at September 30, 2026, primarily reflecting BRL 112.28 million from swap settlements.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Comerc Energia SA published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny

CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.

智通财经•2026/11/09 06:37
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny